Bank of America Corp DE raised its holdings in shares of Alector Inc (NASDAQ:ALEC) by 91.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Adverum Biotechnologies (NASDAQ:ADVM) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs.Alector (NASDAQ:ALEC) initiated with Buy rating and $32 (21% upside) price target at

Alector (NASDAQ:ALEC) Shares Up 5.5%

08:22am, Sunday, 26'th Apr 2020
Alector Inc (NASDAQ:ALEC)’s stock price shot up 5.5% on Friday . The company traded as high as $25.60 and last traded at $25.32, 362,895 shares were traded during trading. A decline of 42% from the
DEMENTIA is a debilitating condition which currently has no cure. But a person may be able to reduce their risk of developing the condition - avoiding certain combinations of food could help.
Alector (NASDAQ:ALEC) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, BidAskClub reports. Several other equi
Bank of New York Mellon Corp increased its stake in shares of Alector Inc (NASDAQ:ALEC) by 23.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi

Alector Inc (NASDAQ:ALEC) Short Interest Update

09:18am, Tuesday, 21'st Apr 2020
Alector Inc (NASDAQ:ALEC) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 5,380,000 shares, a drop of 8.3% from the March 15th total of 5
Alliancebernstein L.P. boosted its position in Alector Inc (NASDAQ:ALEC) by 22.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 30,100 shares of the c
Alector (NASDAQ:ALEC) had its target price boosted by Morgan Stanley from $27.00 to $29.00 in a research report released on Wednesday morning, BenzingaRatingsTable reports. Morgan Stanley currently ha
Alector Inc (NASDAQ:ALEC) insider Robert Paul sold 10,000 shares of Alector stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $22.27, for a total value of
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 23,231 shares of the firm’s stock in a transaction on Tuesday, April 14th. The stock was sold at an average price of $23.52, for
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 62,183 shares of the stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $23.5
In a report released today, Matthew Harrison from Morgan Stanley maintained a Buy rating on Alector (ALEC), with a price target of $29.00. The company's

Alector (NASDAQ:ALEC) Downgraded by BidaskClub

07:44am, Wednesday, 15'th Apr 2020
Alector (NASDAQ:ALEC) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, BidAskClub report
Today is shaping up negative for Alector, Inc. (NASDAQ:ALEC) shareholders, with the analysts delivering a substantial...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE